Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | -7.64%1.97B | 2.96%4.63B | 3.99%2.14B | 48.23%4.49B | 132.11%2.05B | -16.88%3.03B | -14.18%885.33M | 85.48%3.65B | 80.57%1.03B | -56.07%1.97B |
| Operating income | -7.64%1.97B | 2.96%4.63B | 3.99%2.14B | 48.23%4.49B | 132.11%2.05B | -16.88%3.03B | -14.18%885.33M | 85.48%3.65B | 80.57%1.03B | -56.07%1.97B |
| Cost of sales | 5.63%-1.44B | -5.41%-3.14B | -16.89%-1.53B | -9.38%-2.98B | -27.57%-1.31B | 12.81%-2.72B | -5.02%-1.02B | -65.19%-3.12B | -63.80%-974.59M | 28.73%-1.89B |
| Operating expenses | 5.63%-1.44B | -5.41%-3.14B | -16.89%-1.53B | -9.38%-2.98B | -27.57%-1.31B | 12.81%-2.72B | -5.02%-1.02B | -65.19%-3.12B | -63.80%-974.59M | 28.73%-1.89B |
| Gross profit | -12.67%533.33M | -1.85%1.49B | -18.48%610.74M | 391.27%1.52B | 642.07%749.22M | -41.16%308.41M | -342.35%-138.22M | 592.40%524.17M | 340.55%57.03M | -95.85%75.7M |
| Selling expenses | 10.97%-101.42M | 10.12%-245.6M | 23.80%-113.92M | 17.61%-273.26M | -24.33%-149.5M | 5.37%-331.65M | 44.17%-120.24M | 13.06%-350.47M | -6.89%-215.38M | 24.50%-403.12M |
| Administrative expenses | -14.60%-405.18M | -3.96%-845.43M | 9.88%-353.56M | -1.83%-813.26M | -5.96%-392.32M | 6.95%-798.63M | 3.50%-370.25M | 1.80%-858.3M | 4.86%-383.69M | 12.49%-874.07M |
| Revaluation surplus | -24.52%-123.33M | -1,061.20%-222.09M | -439.40%-99.05M | 78.92%-19.13M | 203.19%29.18M | -350.24%-90.72M | -193.09%-28.28M | 119.78%36.26M | 133.77%30.38M | -405.74%-183.27M |
| -Changes in the fair value of investment property | -24.52%-123.33M | -1,061.20%-222.09M | -439.40%-99.05M | 78.92%-19.13M | 203.19%29.18M | -350.24%-90.72M | -193.09%-28.28M | 119.78%36.26M | 133.77%30.38M | -405.74%-183.27M |
| Impairment and provision | ---- | ---32.91M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Impairment of property, machinery and equipment | ---- | ---32.91M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Special items of operating profit | -28.04%52.77M | 9.60%168.72M | 52.10%73.34M | -35.49%153.94M | -67.71%48.22M | -55.85%238.61M | -54.25%149.31M | -10.40%540.41M | 386.11%326.37M | 85.06%603.16M |
| Operating profit | -137.29%-43.83M | -45.02%309.74M | -58.72%117.55M | 183.59%563.41M | 156.10%284.8M | -524.43%-673.98M | -173.97%-507.68M | 86.19%-107.94M | 71.55%-185.3M | -234.62%-781.6M |
| Financing income | -48.25%13.3M | -21.71%51.13M | -6.51%25.69M | 22.72%65.31M | 1.16%27.48M | -28.84%53.22M | -16.89%27.16M | 9.09%74.79M | -18.52%32.69M | -21.70%68.55M |
| Financing cost | -11.48%-6.09M | 14.15%-10.92M | ---5.46M | ---12.72M | ---- | ---- | ---- | ---- | ---- | ---- |
| Share of profits of associates | 3.55%28.39M | -20.73%71.08M | -14.10%27.41M | 273.03%89.68M | 56.56%31.91M | -167.73%-51.83M | -16.01%20.39M | 438.40%76.52M | 147.18%24.27M | -134.16%-22.61M |
| Share of profit from joint venture company | 1,167.65%431K | 30.21%-2.56M | 102.05%34K | 70.02%-3.66M | 70.06%-1.66M | 56.26%-12.22M | 52.88%-5.53M | -353.57%-27.94M | ---11.74M | ---6.16M |
| Earning before tax | -104.72%-7.81M | -40.39%418.47M | -51.76%165.23M | 202.51%702M | 173.56%342.54M | -4,537.90%-684.81M | -232.41%-465.66M | 102.08%15.43M | 78.86%-140.09M | -201.02%-741.82M |
| Tax | -3.25%-66.95M | 39.74%-214.83M | 11.71%-64.84M | -1,957.11%-356.51M | -2,274.80%-73.44M | 117.94%19.2M | -88.18%3.38M | -182.49%-107.02M | -79.05%28.57M | 166.01%129.74M |
| After-tax profit from continuing operations | -174.47%-74.76M | -41.06%203.64M | -62.69%100.39M | 151.91%345.49M | 158.21%269.09M | -626.76%-665.62M | -314.52%-462.29M | 85.04%-91.59M | 78.81%-111.52M | -213.82%-612.08M |
| Earning after tax | -174.47%-74.76M | -41.06%203.64M | -62.69%100.39M | 151.91%345.49M | 158.21%269.09M | -626.76%-665.62M | -314.52%-462.29M | 85.04%-91.59M | 78.81%-111.52M | -213.82%-612.08M |
| Minority profit | -67.45%12.09M | -7.82%97.67M | -17.18%37.16M | 134.20%105.95M | 125.32%44.87M | -16.65%-309.82M | -51.77%-177.18M | -20.02%-265.6M | -41.02%-116.74M | -246.66%-221.29M |
| Profit attributable to shareholders | -237.36%-86.85M | -55.76%105.97M | -71.80%63.23M | 167.33%239.55M | 178.65%224.23M | -304.46%-355.79M | -5,562.77%-285.1M | 144.53%174.02M | 101.18%5.22M | -201.01%-390.79M |
| Basic earnings per share | -237.72%-0.0157 | -55.89%0.0191 | -71.85%0.0114 | 167.34%0.0433 | 178.64%0.0405 | -304.78%-0.0643 | -5,822.22%-0.0515 | 144.48%0.0314 | 101.12%0.0009 | -199.72%-0.0706 |
| Diluted earnings per share | -237.72%-0.0157 | -55.89%0.0191 | -71.85%0.0114 | 167.34%0.0433 | 178.64%0.0405 | -304.78%-0.0643 | -5,822.22%-0.0515 | 144.48%0.0314 | 101.12%0.0009 | -199.72%-0.0706 |
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Ernst & Young | -- | Ernst & Young | -- | KPMG | -- | KPMG | -- | KPMG |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.